These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27420626)

  • 1. [Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease].
    Grigorieva DV; Gorudko IV; Kostevich VA; Sokolov AV; Buko IV; Vasilyev VB; Polonetsky LZ; Panasenko OM; Cherenkevich SN
    Biomed Khim; 2016 Mar; 62(3):318-24. PubMed ID: 27420626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
    Aminian A; Boudjeltia KZ; Babar S; Van Antwerpen P; Lefebvre P; Crasset V; Leone A; Ducobu J; Friart A; Vanhaeverbeek M
    Eur J Intern Med; 2009 Sep; 20(5):527-32. PubMed ID: 19712859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes.
    Liang J; Zheng Z; Wang M; Han L; Zheng Z; Peng J; Liu Z; Wei Y
    J Int Med Res; 2009; 37(3):862-6. PubMed ID: 19589271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
    Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
    Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between fasting plasma glucose and MPO in patients with acute coronary syndrome.
    Zhang X; Dong L; Wang Q; Xie X
    BMC Cardiovasc Disord; 2015 Aug; 15():93. PubMed ID: 26307104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myeloperoxidase in the plasma of patients with acute coronary syndrome].
    Ouyang M; Yang K; Zhang MX; Jiang WH; Cao Y; Wang JG; Gao YD
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):901-5. PubMed ID: 17213593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTH- and cortisol-associated neutrophil modulation in coronary artery disease patients undergoing stent implantation.
    Keresztes M; Horváth T; Ocsovszki I; Földesi I; Serfőző G; Boda K; Ungi I
    PLoS One; 2013; 8(8):e71902. PubMed ID: 23967262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain.
    Granér M; Tikkanen E; Rimpilä O; Tikkanen H; Ripatti S; Lokki ML; Nieminen MS; Taskinen MR; Sinisalo J
    Ann Med; 2013 Jun; 45(4):322-7. PubMed ID: 23651064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients.
    Martínez GJ; Barraclough JY; Nakhla S; Kienzle V; Robertson S; Mallat Z; Celermajer DS; Patel S
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27913753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome].
    Li L; Zhang Y; Chen YG; Li GS; Wang Y; Ma X; Li JF; Zhong M; Zhang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1106-8. PubMed ID: 16563281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactoferrin, myeloperoxidase, and ceruloplasmin: complementary gearwheels cranking physiological and pathological processes.
    Sokolov AV; Zakharova ET; Kostevich VA; Samygina VR; Vasilyev VB
    Biometals; 2014 Oct; 27(5):815-28. PubMed ID: 24966132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between ceruloplasmin, lactoferrin and myeloperoxidase in meconium.
    Skarżyńska E; Żytyńska-Daniluk J; Lisowska-Myjak B
    J Trace Elem Med Biol; 2017 Sep; 43():58-62. PubMed ID: 27903408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between HDL particles size and myeloperoxidase/ paraoxonase-1 (MPO/PON1) ratio in patients with acute coronary syndrome.
    Emami Razavi A; Basati G; Varshosaz J; Abdi S
    Acta Med Iran; 2013 Jul; 51(6):365-71. PubMed ID: 23852840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human neutrophil lipocalin, a highly specific marker for acute exacerbation in cystic fibrosis.
    Eichler I; Nilsson M; Rath R; Enander I; Venge P; Koller DY
    Eur Respir J; 1999 Nov; 14(5):1145-9. PubMed ID: 10596704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome.
    Blanchet X; Cesarek K; Brandt J; Herwald H; Teupser D; Küchenhoff H; Karshovska E; Mause SF; Siess W; Wasmuth H; Soehnlein O; Koenen RR; Weber C; von Hundelshausen P
    Thromb Haemost; 2014 Dec; 112(6):1277-87. PubMed ID: 25183015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum myeloperoxidase activities are significantly associated with the prevalence of ACS and High LDL-C levels in CHD patients.
    Liu C; Xie G; Huang W; Yang Y; Li P; Tu Z
    J Atheroscler Thromb; 2012; 19(5):435-43. PubMed ID: 22659527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in serum concentrations of C-reactive protein, ceruloplasmin, lactoferrin and myeloperoxidase and their interactions during normal human pregnancy and postpartum period.
    Skarżyńska E; Zborowska H; Jakimiuk AJ; Karlińska M; Lisowska-Myjak B
    J Trace Elem Med Biol; 2018 Mar; 46():83-87. PubMed ID: 29413114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cells serve as intravascular carriers of myeloperoxidase.
    Adam M; Gajdova S; Kolarova H; Kubala L; Lau D; Geisler A; Ravekes T; Rudolph V; Tsao PS; Blankenberg S; Baldus S; Klinke A
    J Mol Cell Cardiol; 2014 Sep; 74():353-63. PubMed ID: 24976018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.